Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

A Randomized Trial of Convalescent Plasma in Covid-19 Severe Pneumonia
Ventura Simonovich, Leandro Daniel Burgos Pratx, Paula Scibona, et al.
New England Journal of Medicine (2020) Vol. 384, Iss. 7, pp. 619-629
Open Access | Times Cited: 908

Showing 1-25 of 908 citing articles:

Features, Evaluation and Treatment Coronavirus (COVID-19)
Marco Cascella, Michael Rajnik, Arturo Cuomo, et al.
StatPearls (2020)
Closed Access | Times Cited: 2796
Mechanisms of SARS-CoV-2 entry into cells
Cody B. Jackson, Michael Farzan, Bing Chen, et al.
Nature Reviews Molecular Cell Biology (2021) Vol. 23, Iss. 1, pp. 3-20
Open Access | Times Cited: 2410
SARS-CoV-2 evolution during treatment of chronic infection
Steven A. Kemp, Dami A. Collier, Rawlings Datir, et al.
Nature (2021) Vol. 592, Iss. 7853, pp. 277-282
Open Access | Times Cited: 984
Early High-Titer Plasma Therapy to Prevent Severe Covid-19 in Older Adults
Romina Libster, Gonzalo Pérez Marc, Diego Wappner, et al.
New England Journal of Medicine (2021) Vol. 384, Iss. 7, pp. 610-618
Open Access | Times Cited: 858
Neutralizing monoclonal antibodies for treatment of COVID-19
Peter C. Taylor, Andrew C. Adams, Matthew M. Hufford, et al.
Nature reviews. Immunology (2021) Vol. 21, Iss. 6, pp. 382-393
Open Access | Times Cited: 706
Convalescent plasma in patients admitted to hospital with COVID-19 (RECOVERY): a randomised controlled, open-label, platform trial
Obbina Abani, Ali Abbas, Fatima Abbas, et al.
The Lancet (2021) Vol. 397, Iss. 10289, pp. 2049-2059
Open Access | Times Cited: 471
Surviving Sepsis Campaign Guidelines on the Management of Adults With Coronavirus Disease 2019 (COVID-19) in the ICU: First Update
Waleed Alhazzani, Laura Evans, Fayez Alshamsi, et al.
Critical Care Medicine (2021) Vol. 49, Iss. 3, pp. e219-e234
Open Access | Times Cited: 360
Convalescent plasma or hyperimmune immunoglobulin for people with COVID-19: a living systematic review
Vanessa Piechotta, Khai Li Chai, Sarah J Valk, et al.
Cochrane library (2020)
Open Access | Times Cited: 327
COVID-19: breaking down a global health crisis
Saad I. Mallah, Omar Ghorab, Sabrina Al-Salmi, et al.
Annals of Clinical Microbiology and Antimicrobials (2021) Vol. 20, Iss. 1
Open Access | Times Cited: 305
Lessons learned 1 year after SARS-CoV-2 emergence leading to COVID-19 pandemic
Kelvin Kai‐Wang To, Siddharth Sridhar, Kelvin Hei‐Yeung Chiu, et al.
Emerging Microbes & Infections (2021) Vol. 10, Iss. 1, pp. 507-535
Open Access | Times Cited: 297
Phase 1 randomized trial of a plant-derived virus-like particle vaccine for COVID-19
Brian J. Ward, Philipe Gobeil, Annie Séguin, et al.
Nature Medicine (2021) Vol. 27, Iss. 6, pp. 1071-1078
Open Access | Times Cited: 269
Preexisting autoantibodies to type I IFNs underlie critical COVID-19 pneumonia in patients with APS-1
Paul Bastard, Elizaveta Orlova, Leila Sozaeva, et al.
The Journal of Experimental Medicine (2021) Vol. 218, Iss. 7
Open Access | Times Cited: 252
Convalescent plasma for hospitalized patients with COVID-19: an open-label, randomized controlled trial
Philippe Bégin, Jeannie Callum, Erin Jamula, et al.
Nature Medicine (2021) Vol. 27, Iss. 11, pp. 2012-2024
Open Access | Times Cited: 243
Emerging Variants of SARS-CoV-2 And Novel Therapeutics Against Coronavirus (COVID-19)
Abdul Aleem, Abdul Samad, Amy Slenker
(2021) Vol. 01, pp. 01-01
Closed Access | Times Cited: 242
Pathogenesis and treatment of cytokine storm in COVID-19
Mehmet Soy, Gökhan Keser, Pamir Atagündüz
TURKISH JOURNAL OF BIOLOGY (2021) Vol. 45, Iss. SI-1, pp. 372-389
Open Access | Times Cited: 229
Association of Convalescent Plasma Treatment With Clinical Outcomes in Patients With COVID-19
Perrine Janiaud, Cathrine Axfors, Andreas M. Schmitt, et al.
JAMA (2021) Vol. 325, Iss. 12, pp. 1185-1185
Open Access | Times Cited: 227
Management of hospitalised adults with coronavirus disease 2019 (COVID-19): a European Respiratory Society living guideline
James D. Chalmers, Megan Crichton, Pieter Goeminne, et al.
European Respiratory Journal (2021) Vol. 57, Iss. 4, pp. 2100048-2100048
Open Access | Times Cited: 201
Convalescent plasma or hyperimmune immunoglobulin for people with COVID-19: a living systematic review
Vanessa Piechotta, Claire Iannizzi, Khai Li Chai, et al.
Cochrane library (2021) Vol. 2021, Iss. 5
Open Access | Times Cited: 188
Neutralising antibodies in Spike mediated SARS-CoV-2 adaptation
Steven A. Kemp, Dami A. Collier, Rawlings Datir, et al.
medRxiv (Cold Spring Harbor Laboratory) (2020)
Open Access | Times Cited: 176
Association of Convalescent Plasma Therapy With Survival in Patients With Hematologic Cancers and COVID-19
Michael A. Thompson, Jeffrey P. Henderson, Pankil Shah, et al.
JAMA Oncology (2021) Vol. 7, Iss. 8, pp. 1167-1167
Open Access | Times Cited: 171
COVID-19: Unmasking Emerging SARS-CoV-2 Variants, Vaccines and Therapeutic Strategies
Renuka Raman, Krishna Patel, Kishu Ranjan
Biomolecules (2021) Vol. 11, Iss. 7, pp. 993-993
Open Access | Times Cited: 166
COVID-19 is a systemic vascular hemopathy: insight for mechanistic and clinical aspects
David M. Smadja, Steven J. Mentzer, Michaëla Fontenay, et al.
Angiogenesis (2021) Vol. 24, Iss. 4, pp. 755-788
Open Access | Times Cited: 164
A randomized double-blind controlled trial of convalescent plasma in adults with severe COVID-19
Max R. O’Donnell, Beatriz Grinsztejn, Matthew J. Cummings, et al.
Journal of Clinical Investigation (2021) Vol. 131, Iss. 13
Open Access | Times Cited: 160
The Effect of Convalescent Plasma Therapy on Mortality Among Patients With COVID-19: Systematic Review and Meta-analysis
Stephen A. Klassen, Jonathon W. Senefeld, Patrick W. Johnson, et al.
Mayo Clinic Proceedings (2021) Vol. 96, Iss. 5, pp. 1262-1275
Open Access | Times Cited: 148
Early Convalescent Plasma for High-Risk Outpatients with Covid-19
Frederick K. Korley, Valerie Durkalski‐Mauldin, Sharon D. Yeatts, et al.
New England Journal of Medicine (2021) Vol. 385, Iss. 21, pp. 1951-1960
Open Access | Times Cited: 140
Page 1 - Next Page

Scroll to top